-
Adipose chemokine ligand CX3CL1 contributes to maintaining the hippocampal BDNF level, and the effect is attenuated in advanced age Geroscience (IF 5.3) Pub Date : 2025-02-13 Yoshinori Takei, Yoko Amagase, Ai Goto, Ryuichi Kambayashi, Hiroko Izumi-Nakaseko, Akira Hirasawa, Atsushi Sugiyama
Aging alters signaling that involves brain-derived neurotrophic factor (BDNF) in the hippocampus. An adequate level of BDNF is essential for maintaining cognitive function in older adults. Previously, we showed that repeated intraperitoneal administration of the chemokine ligand CX3CL1 modulates peritoneal immune cells and the vagal nerve to increase hippocampal BDNF, consequently improving cognitive
-
Measuring thymic output across the human lifespan: a critical challenge in laboratory medicine Geroscience (IF 5.3) Pub Date : 2025-02-13 Vera Middelkamp, Eliisa Kekäläinen
Age-associated thymic involution leads to a significant decline in thymic T cell output, a major contributor to immunosenescence in the elderly. Accurately measuring thymic output is therefore critical for understanding the mechanisms behind immune aging. Furthermore, robust quantification of thymic output is essential in various other clinical and research settings, including the diagnosis of immunodeficiencies
-
A multi-omic single-cell landscape of the aging mouse ovary Geroscience (IF 5.3) Pub Date : 2025-02-11 Jian Zhang, Shunze Jia, Zehua Zheng, Lanrui Cao, Jingyi Zhou, Xudong Fu
The ovary is one of the first organs in humans to exhibit age-related functional impairments. As an organ composed of diverse heterogeneous cell types, the ovary exhibits cell-type-specific changes during the aging process, ultimately leading to a decline in female fertility. Investigating the molecular mechanisms of ovarian aging is crucial for understanding age-related fertility dysfunction in females
-
Unraveling the link between frailty and Alzheimer’s disease biomarkers in patients with mild cognitive impairment Geroscience (IF 5.3) Pub Date : 2025-02-10 Simona Buscarnera, Marco Canevelli, Giuseppe Bruno, Valentina Garibotto, Giovanni Battista Frisoni, Federica Ribaldi
Alzheimer’s disease (AD) can be identified through biomarkers of amyloid (A) and tau (T) pathology. Frailty, a measure of biological aging, could impact the association between AD neuropathology and its clinical manifestation. We aimed to investigate the relationship between frailty and AD biomarkers among people with mild cognitive impairment (MCI) attending a university memory clinic. Data were collected
-
The role of protective genetic variants in modulating epigenetic aging Geroscience (IF 5.3) Pub Date : 2025-02-10 Yosra Bejaoui, Luma Srour, Abeer Qannan, Junko Oshima, Chadi Saad, Steve Horvath, Hamdi Mbarek, Nady El Hajj
Several progeroid syndromes’ causative mutations have been linked to epigenetic age acceleration as measured via several epigenetic clocks. At the same time, several protective variants have also been discovered that can reduce the risk of developing certain age-related disorders. However, the impact of these protective variants on epigenetic aging has not been well elucidated. Our research, which
-
Impact of Mlkl or Ripk3 deletion on age-associated liver inflammation, metabolic health, and lifespan Geroscience (IF 5.3) Pub Date : 2025-02-10 Sabira Mohammed, Phoebe Ohene-Marfo, Chao Jiang, Zongkai Peng, Nidheesh Thadathil, Albert Tran, Evan Nicklas, Shylesh Bhaskaran, Dawei Wang, Ramasamy Selvarani, Amit Singh, Zhibo Yang, Nagib Ahsan, Sathyaseelan S. Deepa
Chronic, low-grade inflammation is a hallmark of aging and various age-related diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD). The prevalence of metabolic dysfunction-associated steatohepatitis (MASH), an advanced form of MASLD, increases with age and contributes to morbidity and mortality among the elderly. This study investigates the role of necroptosis, a programmed
-
In vivo medical imaging for assessing geroprotective interventions in humans Geroscience (IF 5.3) Pub Date : 2025-02-06 Jonas E. Svensson, Martin Schain, Pontus Plavén-Sigray
There is a growing interest in developing drugs with a general geroprotective effect, aimed at slowing down aging. Several compounds have been shown to increase the lifespan and reduce the incidence of age-related diseases in model organisms. Translating these results is challenging, due to the long lifespan of humans. To address this, we propose using a battery of medical imaging protocols that allow
-
Workload and clinical impact of MRI-based extension of reperfusion therapy time window in acute ischaemic stroke—a prospective single-centre study Geroscience (IF 5.3) Pub Date : 2025-02-06 Tímea Tünde Takács, Rita Magyar-Stang, Szabolcs Szatmári, Ildikó Sipos, Katalin Saftics, Ádám József Berki, Sándor Évin, Dániel Bereczki, Csaba Varga, Nóra Nyilas, István Bíró, Péter Barsi, Máté Magyar, Pál Maurovich-Horvat, Péter Pál Böjti, Máté Pásztor, István Szikora, Sándor Nardai, Bence Gunda
Current European Stroke Organisation (ESO) guidelines recommend extended time window reperfusion therapies (4.5–9 h for thrombolysis, 6–24 h for thrombectomy) based on advanced imaging. However, the workload and clinical benefit of this strategy on a population basis are not known. To determine the caseload, treatment rates, and outcomes in the extended as compared to the standard time windows. All
-
Fecal microbiota transplant from long-living Ames dwarf mice alters the microbial composition and biomarkers of liver health in normal mice Geroscience (IF 5.3) Pub Date : 2025-02-04 Sarah A. Ashiqueali, Natalie Hayslip, Diptaraj S. Chaudhari, Augusto Schneider, Xiang Zhu, Blazej Rubis, Corey E. Seavey, Md Tanjim Alam, Ridwan Hussein, Sarah A. Noureddine, Ewelina Golusinska-Kardach, Pawel Pazdrowski, Hariom Yadav, Michal M. Masternak
Aging is associated with intestinal dysbiosis, a condition characterized by diminished microbial biodiversity and inflammation. This leads to increased vulnerability to extraintestinal manifestations such as autoimmune, metabolic, and neurodegenerative conditions thereby accelerating mortality. As such, modulation of the gut microbiome is a promising way to extend healthspan. In this study, we explore
-
A cohort study reveals shared and distinct serum metabolic biomarkers for major adverse cardiovascular events in middle-aged and older adults Geroscience (IF 5.3) Pub Date : 2025-02-04 Yi Ren, Bo Chen, Honggang Zhang, Shaoyong Xu
We assessed the association of serum metabolites with the occurrence of major adverse cardiovascular events (MACE) in middle-aged and elderly individuals, explored the value of metabolomics in predicting MACE, and compared the distinctions in MACE risk-related metabolic biomarkers between middle-aged and elderly groups. Among the participants of the UK Biobank who underwent baseline assessment through
-
Synergistic effects of plasma S100B and MRI measures of cerebrovascular disease on cognition in older adults Geroscience (IF 5.3) Pub Date : 2025-02-05 Colleen Pappas, Christopher E. Bauer, Valentinos Zachariou, T. J. Libecap, Beatriz Rodolpho, Tiffany L. Sudduth, Peter T. Nelson, Gregory A. Jicha, Anika MS Hartz, Xingfeng Shao, Danny J. J. Wang, Brian T. Gold
There is growing interest in studying vascular contributions to cognitive impairment and dementia (VCID) and developing biomarkers to identify at-risk individuals. A combination of biofluid and neuroimaging markers may better profile early stage VCID than individual measures. Here, we tested this possibility focusing on plasma levels of S100 calcium-binding protein B (S100B), which has been linked
-
Inhibition of soluble epoxide hydrolase ameliorates cerebral blood flow autoregulation and cognition in alzheimer's disease and diabetes-related dementia rat models Geroscience (IF 5.3) Pub Date : 2025-02-04 Chengyun Tang, Jane J. Border, Huawei Zhang, Andrew Gregory, Shan Bai, Xing Fang, Yedan Liu, Shaoxun Wang, Sung Hee Hwang, Wenjun Gao, Gilbert C. Morgan, Jhania Smith, David Bunn, Cameron Cantwell, Karen M. Wagner, Christophe Morisseau, Jun Yang, Seung Min Shin, Philip O’Herron, Zsolt Bagi, Jessica A. Filosa, Yanbin Dong, Hongwei Yu, Bruce D. Hammock, Richard J. Roman, Fan Fan
Alzheimer's Disease and Alzheimer's Disease-related dementias (AD/ADRD) pose major global healthcare challenges, with diabetes mellitus (DM) being a key risk factor. Both AD and DM-related ADRD are characterized by reduced cerebral blood flow, although the exact mechanisms remain unclear. We previously identified compromised cerebral hemodynamics as early signs in TgF344-AD and type 2 DM-ADRD (T2DN)
-
Intrinsic brain functional connectivity mediates the relationship between psychological resilience and cognitive decline in ageing Geroscience (IF 5.3) Pub Date : 2025-02-03 Menglu Chen, Mengxia Gao, Junji Ma, Tatia M. C. Lee
Ageing individuals often experience cognitive decline and intrinsic functional connectivity (FC) changes. Psychological resilience, a personality trait that reflects the capacity to adapt and cope with age-related challenges, plays a key role in mitigating cognitive decline. In this study involving 101 older adults, we investigated how psychological resilience influences cognitive decline measured
-
Effects of home-based exercise with or without cognitive training on cognition and mobility in cardiac patients: A randomized clinical trial Geroscience (IF 5.3) Pub Date : 2025-02-03 Florent Besnier, Emma Gabrielle Dupuy, Christine Gagnon, Thomas Vincent, Tudor Vrinceanu, Caroll-Ann Blanchette, Josep Iglesies-Grau, Kathia Saillant, Malorie Chabot-Blanchet, Sylvie Belleville, Martin Juneau, Paolo Vitali, Mathieu Gayda, Anil Nigam, Louis Bherer
This randomized controlled trial compared the effects of home-based exercise, with or without cognitive training, on cognition and physical function in individuals aged 50 years and older with stable CVD during the COVID-19 pandemic. 122 patients (67.3 ± 7.9 years, 71% men) with stable CVD (77% coronary heart disease) were randomly assigned (1:1) to (1) Home-based physical exercise alone, or (2) Home-based
-
The prognostic and neuroendocrine implications of SLC25A29-mediated biomass signature in prostate cancer Geroscience (IF 5.3) Pub Date : 2025-01-31 Chia-Chang Wu, Su-Wei Hu, Shao-Wei Dong, Kai-Yi Tzou, Chien Hsiu Li
Dysregulated solutes are linked to cancer progression, with associated carriers being potential targets for prognosis and treatment. Androgen deprivation therapy (ADT) is essential for prostate cancer (PCa) progression, but secondary resistance often leads to androgen-independent tumor growth, necessitating new prognostic biomarkers. Transcriptome-based datasets identify SLC25A29, an arginine carrier
-
The unity/diversity framework of executive functions: behavioral and neural evidence in older adults Geroscience (IF 5.3) Pub Date : 2025-01-31 Sheng-Ju Guo, Ping Wang, Li-Zhi Cao, Hui-Jie Li
Executive functions (EFs), encompassing inhibition, shifting, and updating as three fundamental subdomains, are typically characterized by a unity/diversity construct. However, given the dedifferentiation trend observed in aging, it remains controversial whether the construct of EFs in older adults becomes unidimensional or maintains unity/diversity. This study aims to explore and validate the construct
-
Comparative phenotyping of C57BL/6J substrains reveals distinctive patterns of cardiac aging Geroscience (IF 5.3) Pub Date : 2025-01-30 Sophia Walter, Patricia Baumgarten, Niklas Hegemann, Steffen P. Häseli, Stefanie Deubel, Julia Jelleschitz, Annika Höhn, Nikolaus Berndt, Wolfgang M. Kuebler, Jana Grune, Christiane Ott
Research in aging often refers to animal models, particularly C57BL/6J (B6J) mice, considered gold standard. However, B6J mice are distributed by different suppliers, which results in divers substrains exhibiting notable phenotypic differences. To ensure a suitable phenotype of cardiac aging, we performed heart analyses of young (5 months) and old B6J mice (24 months) from two substrains: B6JRj (Janvier)
-
Role for neurological and immunological resilience in the pathway of the aging muscle powerpenia: InCHIANTI study longitudinal results Geroscience (IF 5.3) Pub Date : 2025-01-30 Raffaello Pellegrino, Roberto Paganelli, Angelo Di Iorio, Matteo Candeloro, Stefano Volpato, Stefania Bandinelli, Antimo Moretti, Giovanni Iolascon, Toshiko Tanaka, Luigi Ferrucci
The neuromuscular junction shows several degenerative changes with aging, resulting in a reduction of transmission efficacy. These changes, paired with low-grade chronic inflammation, were considered triggers of the aging muscle processes. The main objective of this study is to assess the role of leukocyte count–derived ratios, nerve conduction velocity (NCV), and compound muscle action potential (CMAP)
-
An mTOR inhibitor discovery system using drug-sensitized yeast Geroscience (IF 5.3) Pub Date : 2025-01-30 Anna K. Breen, Sarah Thomas, David Beckett, Matthew Agsalud, Graham Gingras, Judd Williams, Brian M. Wasko
Inhibition of the target of rapamycin (TOR/mTOR) protein kinase by the drug rapamycin extends lifespan and health span across diverse species. However, rapamycin has potential off-target and side effects that warrant the discovery of additional TOR inhibitors. TOR was initially discovered in Saccharomyces cerevisiae (yeast) which contains two TOR paralogs, TOR1 and TOR2. Yeast lacking functional Tor1
-
Better objective sleep quality is associated with higher gut microbiota richness in older adults Geroscience (IF 5.3) Pub Date : 2025-01-31 Maria Teresa Wijaya, Ji-Tseng Fang, Geng-Hao Liu, Yuan-Ming Yeh, Ning-Hung Chen, Chih-Ming Lin, Kuain-Yi Wu, Chih-Mao Huang, Shwu-Hua Lee, Tatia M. C. Lee
Aging is associated with disrupted sleep patterns, such as fragmented sleep and reduced efficiency, leading to negative health outcomes. There is evidence of a bidirectional relationship between sleep and gut microbiota, which plays a key role in the gut-brain axis and overall health. However, studies on this relationship in older adults have limited generalizability and show conflicting results, highlighting
-
Combining non-invasive brain stimulation techniques and EEG markers analysis: an innovative approach to cognitive health in aging Geroscience (IF 5.3) Pub Date : 2025-01-31 Chiara Pappalettera, Anna Fabbrocino, Francesca Miraglia, Paolo Maria Rossini, Fabrizio Vecchio
In an era marked by a rapidly aging global population, delving into the intricate neurophysiological changes that accompany the aging process assumes paramount importance. This narrative review offers a comprehensive exploration of the intricate relationship between electromagnetic neuromodulation and electroencephalography (EEG) within the context of aging. Moreover, it showed the promising landscape
-
Dynamic proportional loss of functional connectivity revealed change of left superior frontal gyrus in subjective cognitive decline: an explanatory study based on Chinese and Western cohorts Geroscience (IF 5.3) Pub Date : 2025-01-31 Luyao Wang, Wenjing Hu, Fan Dong, Can Sheng, Jinglong Wu, Ying Han, Jiehui Jiang, Michael W. Weiner, Paul Aisen, Ronald Petersen, Clifford R. Jack, William Jagust, John Q. Trojanowski, Arthur W. Toga, Laurel Beckett, Robert C. Green, Andrew J. Saykin, John Morris, Leslie M. Shaw, Zaven Khachaturian, Greg Sorensen, Lew Kuller, Marcus Raichle, Steven Paul, Peter Davies, Howard Fillit, Franz Hefti, David
Brain network dynamics have been extensively explored in patients with subjective cognitive decline (SCD). However, these studies are susceptible to individual differences, scanning parameters, and other confounding factors. Therefore, how to reveal subtle SCD-related subtle changes remains unclear. Cross-sectional and longitudinal resting-state functional magnetic resonance imaging data from both
-
Nocturia as a clinical marker of loss of function and resilience or risk factor for frailty in older adults? Results of the Berlin Aging Study II Geroscience (IF 5.3) Pub Date : 2025-01-31 Maximilian König, Carolin Malsch, Joany Mariño, Valentin Max Vetter, Yulia Komleva, Ilja Demuth, Elisabeth Steinhagen-Thiessen
The current study examined cross-sectional and longitudinal associations between nocturia and frailty in a cohort of men and women aged 60 years and older, as evidence on this topic was lacking. We analyzed baseline and follow-up data (n = 1671) from the Berlin Aging Study II (BASE-II), a prospective longitudinal cohort study focusing on the factors associated with “healthy” vs. “unhealthy” aging.
-
Stochasticity in dietary restriction-mediated lifespan outcomes in Drosophila Geroscience (IF 5.3) Pub Date : 2025-01-31 Olivia L. Mosley, Joel A. Villa, Advaitha Kamalakkannan, Eliyashaib James, Jessica M. Hoffman, Yang Lyu
Dietary restriction (DR) is widely considered to be one of the most potent approaches to extend healthy lifespan across various species, yet it has become increasingly apparent that DR-mediated longevity is influenced by biological and non-biological factors. We propose that current priorities in the field should include understanding the relative contributions of these factors to elucidate the mechanisms
-
Cardiovascular disease, bone fracture, and all-cause mortality risks among postmenopausal women by arthritis and veteran status: A multistate Markov transition analysis Geroscience (IF 5.3) Pub Date : 2025-01-29 Hind A. Beydoun, May A. Beydoun, Jordan Weiss, Robert Brunner, Nishant K. Mishra, Ming Ding, Jean Wactawski-Wende, Philippe Jean-Luc Gradidge, Simin Liu, Jack Tsai
Arthritis, a chronic inflammatory condition linked to cardiovascular disease (CVD) and bone fracture, is more frequent among military veterans and postmenopausal women. This study examined correlates of arthritis and relationships of arthritis with risks of developing CVD, bone fractures, and mortality among postmenopausal veteran and non-veteran women. We analyzed longitudinal data on 135,790 (3,436
-
Whole-body networks: a holistic approach for studying aging Geroscience (IF 5.3) Pub Date : 2025-01-29 Orestis Stylianou, Johannes M. Meixner, Tilman Schlick, Colin M. Krüger
Aging is a multi-organ disease, yet the traditional approach has been to study each organ in isolation. Such organ-specific studies have provided invaluable information regarding its pathomechanisms. However, an overall picture of the whole-body network (WBN) during aging is still incomplete. In this study, we analyzed the functional magnetic resonance imaging blood-oxygen level-dependent, respiratory
-
Sex-specific transcriptomic profiling reveals key players in bone loss associated with Alzheimer’s disease Geroscience (IF 5.3) Pub Date : 2025-01-29 Mohini Gharpure, Sagar Vyavahare, Diana M. Asante, Jie Chen, Roger Zhong, Marion A. Cooley, Ferenc Deak, Xin-Yun Lu, Carlos M. Isales, Sadanand Fulzele
Alzheimer’s disease (AD), a progressive neurodegenerative disorder, is frequently associated with musculoskeletal complications, including sarcopenia and osteoporosis, which substantially impair patient quality of life. Despite these clinical observations, the molecular mechanisms linking AD to bone loss remain insufficiently explored. In this study, we examined the femoral bone microarchitecture and
-
Preserved brain youthfulness: longitudinal evidence of slower brain aging in superagers Geroscience (IF 5.3) Pub Date : 2025-01-27 Chang-hyun Park, Bori R. Kim, Soo Mee Lim, Eun-Hee Kim, Jee Hyang Jeong, Geon Ha Kim
Background Superagers, older adults with exceptional cognitive abilities, show preserved brain structure compared to typical older adults. We investigated whether superagers have biologically younger brains based on their structural integrity. Methods A cohort of 153 older adults (aged 61-93) was recruited, with 63 classified as superagers based on superior episodic memory and 90 as typical older adults
-
The negative relationship between brain-age gap and psychological resilience defines the age-related neurocognitive status in older people Geroscience (IF 5.3) Pub Date : 2025-01-28 Yue Gu, Nichol M. L. Wong, Chetwyn C. H. Chan, Jingsong Wu, Tatia M. C. Lee
Biological brain age is a brain-predicted age using machine learning to indicate brain health and its associated conditions. The presence of an older predicted brain age relative to the actual chronological age is indicative of accelerated aging processes. Consequently, the disparity between the brain’s chronological age and its predicted age (brain-age gap) and the factors influencing this disparity
-
Attitudes towards healthy eating and its determinants among older adults in a deprived region of Hungary: implications for the National Healthy Aging Program Geroscience (IF 5.3) Pub Date : 2025-01-28 Nora Kovacs, Eva Biro, Peter Piko, Zoltan Ungvari, Roza Adany
A healthy diet is a key determinant of successful aging. However, the psychological, social, and physiological changes associated with ageing often disrupt dietary behaviours. Hungary has one of the highest rates of chronic age-related diseases in the European Union, exacerbated by unhealthy dietary patterns and rapid population aging. This study evaluates attitudes and barriers to healthy eating among
-
The bioavailability and blood levels of low-dose rapamycin for longevity in real-world cohorts of normative aging individuals Geroscience (IF 5.3) Pub Date : 2025-01-28 Girish Harinath, Virginia Lee, Andy Nyquist, Mauricio Moel, Maartje Wouters, Jesper Hagemeier, Brandon Verkennes, Colleen Tacubao, Sayem Nasher, Krister Kauppi, Stefanie L. Morgan, Anar Isman, Sajad Zalzala
Rapamycin, also known as sirolimus, has demonstrated great potential for application in longevity medicine. However, the dynamics of low-dose rapamycin bioavailability, and any differences in bioavailability for different formulations (e.g., compounded or commercial), remain poorly understood. We thus explored rapamycin bioavailability in two real-world cohorts to begin providing a foundational understanding
-
Cognitive variation reflects amyloid, tau, and neurodegenerative biomarkers in Alzheimer’s disease Geroscience (IF 5.3) Pub Date : 2025-01-28 Kia Ann Sean Phang, Chin Hong Tan
In Alzheimer’s disease (AD), the accumulation of neuropathological markers such as amyloid-β plaques, neurofibrillary tangles, and cortical neurodegeneration occurs over many years before overt manifestation of cognitive impairment. There is thus a need for neuropsychological markers that are indicative of pathological changes in the early stages of the disease. Intra-individual cognitive variability
-
Involvement of TGF-β, mTOR, and inflammatory mediators in aging alterations during myxomatous mitral valve disease in a canine model Geroscience (IF 5.3) Pub Date : 2025-01-27 Arkadiusz Grzeczka, Szymon Graczyk, Pawel Kordowitzki
Inflammaging, a state of chronic low-grade inflammation associated with aging, has been linked to the development and progression of various disorders. Cellular senescence, a state of irreversible growth arrest, is another characteristic of aging that contributes to the pathogenesis of cardiovascular pathology. Senescent cells accumulate in tissues over time and secrete many inflammatory mediators
-
Multiplexed single-cell imaging reveals diverging subpopulations with distinct senescence phenotypes during long-term senescence induction Geroscience (IF 5.3) Pub Date : 2025-01-23 Garrett A. Sessions, Madeline V. Loops, Brian O. Diekman, Jeremy E. Purvis
Cellular senescence is a phenotypic state that contributes to the progression of age-related disease through secretion of pro-inflammatory factors known as the senescence-associated secretory phenotype (SASP). Understanding the process by which healthy cells become senescent and develop SASP factors is critical for improving the identification of senescent cells and, ultimately, understanding tissue
-
Blockade of A2AR improved brain perfusion and cognitive function in a mouse model of Alzheimer’s disease Geroscience (IF 5.3) Pub Date : 2025-01-22 Mariana Sayuri Berto Udo, Julia Zaccarelli-Magalhães, Garrett Alan Clemons, Cristiane Teresinha Citadin, Julia Langman, Drew James Smith, Luiz Henrique Matuguma, Vesna Tesic, Hung Wen Lin
Alzheimer’s disease (AD) is a neurodegenerative disorder that affects more than 6.2 million Americans aged 65 and older, particularly women. Along with AD’s main hallmarks (formation of β-amyloid plaques and tau neurofibrillary tangles), there are vascular alterations that occurs in AD pathology. Adenosine A2 receptor (A2AR) is one of the key factors of brain vascular autoregulation and is overexpressed
-
Painful diabetic neuropathy is associated with accelerated epigenetic aging Geroscience (IF 5.3) Pub Date : 2025-01-23 Katarzyna Malgorzata Kwiatkowska, Paolo Garagnani, Massimiliano Bonafé, Maria Giulia Bacalini, Luciano Calzari, Davide Gentilini, Dan Ziegler, Monique M. Gerrits, Catharina G. Faber, Rayaz A. Malik, Margherita Marchi, Erika Salvi, Giuseppe Lauria, Chiara Pirazzini
About one out of two diabetic patients develop diabetic neuropathy (DN), of these 20% experience neuropathic pain (NP) leading to individual, social, and health-economic burden. Risk factors for NP are largely unknown; however, premature aging was recently associated with several chronic pain disorders. DNA methylation-based biological age (DNAm) is associated with disease risk, morbidity, and mortality
-
Depressive intensity, duration, and their associations with cognitive decline: a population-based study in Korea Geroscience (IF 5.3) Pub Date : 2025-01-23 Kai Lu, Wei Wang, Junyu Wang, Qianqian Du, Chen Li, Yuxin Wei, Menghan Yao, Tao Zhang, Fei Yin, Yue Ma
Existing epidemiological studies have ignored the effect of depressive duration on cognitive decline despite the presence of biological cues and understudied the depression-cognition association in Asian countries in the context of increasing cognitive burden worldwide. We aimed to comprehensively characterize the effects of depressive duration and intensity on cognitive decline at the population level
-
Circulating biomarkers associated with walking performance in elderly subjects: exploring miRNAs, metabolic and inflammatory biomarkers Geroscience (IF 5.3) Pub Date : 2025-01-20 Martina Faraldi, Mauro Provinciali, Mirko Di Rosa, Raffaella Moresi, Veronica Sansoni, Marta Gomarasca, Laura Gerosa, Amir Mohammad Malvandi, Fabrizia Lattanzio, Giuseppe Banfi, Giovanni Lombardi
Aging phenotype is characterized by musculoskeletal impairment that leads to diminished mobility and physical function. This study investigated whether circulating miRNAs and metabolic and inflammatory biomarkers may reflect the walking performance of the elderly. Elderly hospitalized for an acute condition and recruited from the ReportAge Biobank were grouped, based on their walking performance, in
-
The senolytic cocktail, dasatinib and quercetin, impacts the chromatin structure of both young and senescent vascular smooth muscle cells Geroscience (IF 5.3) Pub Date : 2025-01-20 Agnieszka Gadecka, Natalia Nowak, Edyta Bulanda, Dorota Janiszewska, Magdalena Dudkowska, Ewa Sikora, Anna Bielak-Zmijewska
One promising strategy to alleviate aging symptoms is the treatment with senolytics that is compounds which selectively eliminate senescent cells. Some therapies aim to reduce symptoms of cellular senescence without senescent cell eradication (senomorphic activity). However, senotherapies raise many questions concerning the selectivity, safety and efficiency of senolitic drugs. A vital question is
-
Serum β-secretase 1 (sBACE1) activity in subjective cognitive decline: an exploratory study Geroscience (IF 5.3) Pub Date : 2025-01-20 Carlo Cervellati, Alessandro Trentini, Valentina Rosta, Angelina Passaro, Gloria Brombo, Carlo Renzini, Gerhard Multhaup, Giovanni Zuliani
β-Secretase-1 (BACE1) plays a key role in the regulation of cerebral amyloid-β homeostasis, being involved in amyloidogenic and, as recently found, amyloidolytic pathways. Growing evidence indicates that increased serum BACE1 (sBACE1) activity might represent an early biomarker for Alzheimer’s disease. Here, we tested the hypothesis that an increase in sBACE1 activity may already occur in individuals
-
Enhancing cognitive functions in aged dogs and cats: a systematic review of enriched diets and nutraceuticals Geroscience (IF 5.3) Pub Date : 2025-01-18 Tiphaine Blanchard, Justine Eppe, Amélie Mugnier, Fabienne Delfour, Annabelle Meynadier
With advancements in veterinary care and the growing recognition of pets as integral member of the family, the lifespans of dogs and cats have significantly increased, leading to a higher prevalence of age-related conditions, including cognitive dysfunction syndrome (CDS). CDS adversely impacts pets’ quality of life and presents emotional and practical challenges for owners. Given its similarities
-
5-HT2C agonism as a neurotherapeutic for sarcopenia: preclinical proof of concept Geroscience (IF 5.3) Pub Date : 2025-01-17 Nathan R. Kerr, Anna R. Dashtmian, Fereshteh B. Darvishi, Charles D. Brennan, Sindhuja N. Ayyagari, Peter J. Moore, Jose A. Viteri, Meifang Wang, Mark M. Rich, Brian C. Clark, W. David Arnold
Sarcopenia, the pathological age-related loss of muscle mass and strength, contributes to physical decline, frailty, and diminished healthspan. The impact of sarcopenia is expected to rise as the aging population grows, and treatments remain limited. Therefore, novel approaches for enhancing physical function and strength in older adults are desperately needed. Recent evidence suggests that deficits
-
Association between inflammatory biomarkers and the cognitive response to a multidomain intervention: secondary longitudinal analyses from the MAPT study Geroscience (IF 5.3) Pub Date : 2025-01-17 Emmanuel Gonzalez-Bautista, Maria Soto, Gabor Abellan van Kan, Julien Delrieu
The aim of this study is to evaluate the association of systemic inflammation measured by plasma biomarkers with the change in cognitive function among participants from the Multidomain Alzheimer Preventive Trial (MAPT) exposed to the multidomain intervention (MI). Secondary analysis of the MAPT longitudinal data. MAPT is a randomized, placebo-controlled trial with 3 interventional groups (omega-3
-
Characterizing biomarkers of ageing in Singaporeans: the ABIOS observational study protocol Geroscience (IF 5.3) Pub Date : 2025-01-17 Jessica K. Lu, Weilan Wang, Janjira Soh, Elena Sandalova, Zhi Meng Lim, Santosh Kumar Seetharaman, Jing-Dong Jackie Han, Desmond B. Teo, Brian K. Kennedy, Jorming Goh, Andrea B. Maier
Ageing is the primary driver of age-associated chronic diseases and conditions. Asian populations have traditionally been underrepresented in studies understanding age-related diseases. Thus, the Ageing BIOmarker Study in Singaporeans (ABIOS) aims to characterise biomarkers of ageing in Singaporeans, exploring associations between molecular, physiological, and digital biomarkers of ageing. This is
-
DNA methylation clocks struggle to distinguish inflammaging from healthy aging, but feature rectification improves coherence and enhances detection of inflammaging Geroscience (IF 5.3) Pub Date : 2025-01-18 Colin M. Skinner, Michael J. Conboy, Irina M. Conboy
Biological age estimation from DNA methylation and determination of relevant biomarkers is an active research problem which has predominantly been tackled with black-box penalized regression. Machine learning is used to select a small subset of features from hundreds of thousands of CpG probes and to increase generalizability typically lacking with ordinary least-squares regression. Here, we show that
-
Light buckets and laser beams: mechanisms and applications of photobiomodulation (PBM) therapy Geroscience (IF 5.3) Pub Date : 2025-01-18 David W. Frankowski, Luigi Ferrucci, Praveen R. Arany, Dawn Bowers, Janis T. Eells, Francisco Gonzalez-Lima, Nicole L. Lohr, Brendan J. Quirk, Harry T. Whelan, Edward G. Lakatta
Photobiomodulation (PBM) therapy, a non-thermal light therapy using nonionizing light sources, has shown therapeutic potential across diverse biological processes, including aging and age-associated diseases. In 2023, scientists from the National Institute on Aging (NIA) Intramural and Extramural programs convened a workshop on the topic of PBM to discuss various proposed mechanisms of PBM action,
-
Substrate stiffness dictates unique doxorubicin-induced senescence-associated secretory phenotypes and transcriptomic signatures in human pulmonary fibroblasts Geroscience (IF 5.3) Pub Date : 2025-01-18 Huixun Du, Jacob P. Rose, Joanna Bons, Li Guo, Taylor R. Valentino, Fei Wu, Jordan B. Burton, Nathan Basisty, Max Manwaring-Mueller, Priya Makhijani, Nan Chen, Veronica Chang, Shawn Winer, Judith Campisi, David Furman, Andras Nagy, Birgit Schilling, Daniel A. Winer
Cells are subjected to dynamic mechanical environments which impart forces and induce cellular responses. In age-related conditions like pulmonary fibrosis, there is both an increase in tissue stiffness and an accumulation of senescent cells. While senescent cells produce a senescence-associated secretory phenotype (SASP), the impact of physical stimuli on both cellular senescence and the SASP is not
-
Healthy aging changes in conventional frequency bands of neuroelectric brain activity reconstructed from resting-state MEG Geroscience (IF 5.3) Pub Date : 2025-01-17 Mikhail Ustinin, Anna Boyko, Stanislav Rykunov
Age-related dependencies of electric and spectral powers in conventional frequency bands were studied by the newly proposed method of detailed spectral analysis. The magnetic encephalograms (MEG) and magnetic resonance images (MRI) of the head were obtained from the open archive Cam-CAN. The spatial distributions of elementary spectral components (MEG-based functional tomograms) were reconstructed
-
Aβ42 biomarker linked to insula, striatum, thalamus and claustrum in dementia with Lewy bodies Geroscience (IF 5.3) Pub Date : 2025-01-17 Vincent Gabriel, Olivier Bousiges, Mary Mondino, Benjamin Cretin, Nathalie Philippi, Candice Muller, Pierre Anthony, Catherine Demuynck, Paulo Loureiro de Sousa, Anne Botzung, Léa Sanna, Eléna Chabran, Frédéric Blanc
The differential mechanisms between proteinopathies and neurodegeneration in Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB) remain unclear. To address this issue, we conducted a voxel-based morphometry and cerebrospinal fluid biomarker (α-synuclein, Aβ42, t-Tau and p-Tau181) level correlation study in patients with DLB, AD and mixed cases (AD + DLB). Cerebrospinal fluid samples obtained
-
The bright and dark side of blue-enriched light on sleep and activity in older adults Geroscience (IF 5.3) Pub Date : 2025-01-17 Débora Barroggi Constantino, Katharina A. Lederle, Benita Middleton, Victoria L. Revell, Tracey L. Sletten, Peter Williams, Debra J. Skene, Daan R. van der Veen
Low indoor light in urban housing can disrupt health and wellbeing, especially in older adults who experience reduced light sensitivity and sleep/circadian disruptions with natural aging. While controlled studies suggest that enhancing indoor lighting may alleviate the negative effects of reduced light sensitivity, evidence for this to be effective in the real world is lacking. This study investigates
-
Deep learning reveals diverging effects of altitude on aging Geroscience (IF 5.3) Pub Date : 2025-01-15 Amanuel Abraha Teklu, Indra Heckenbach, Michael Angelo Petr, Daniela Bakula, Guido Keijzers, Morten Scheibye-Knudsen
Aging is influenced by a complex interplay of multifarious factors, including an individual’s genetics, environment, and lifestyle. Notably, high altitude may impact aging and age-related diseases through exposures such as hypoxia and ultraviolet (UV) radiation. To investigate this, we mined risk exposure data (summary exposure value), disease burden data (disability-adjusted life years (DALYs)), and
-
Lung endothelial cell senescence impairs barrier function and promotes neutrophil adhesion and migration Geroscience (IF 5.3) Pub Date : 2025-01-16 Maliheh Najari Beidokhti, Nuria Villalba, Yonggang Ma, Amanda Reynolds, Juan Hernandez Villamil, Sarah Y. Yuan
Cellular senescence contributes to inflammation and organ dysfunction during aging. While this process is generally characterized by irreversible cell cycle arrest, its morphological features and functional impacts vary in different cells from various organs. In this study, we examined the expression of multiple senescent markers in the lungs of young and aged humans and mice, as well as in mouse lung
-
Dietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging Geroscience (IF 5.3) Pub Date : 2025-01-16 Setor K. Kunutsor, Davinder S. Jassal, Amir Ravandi, Andrea Lehoczki
Flaxseed, a rich source of omega-3 polyunsaturated fatty acid alpha-linolenic acid (ALA), lignans, and soluble fiber, has attracted attention for its potential to improve multiple cardiometabolic risk factors. While its benefits are well-recognized, comprehensive evaluations of its direct impact on clinical outcomes, such as the prevention or progression of cardiometabolic diseases, remain limited
-
The anti-senescence effect of D-β-hydroxybutyrate in Hutchinson-Gilford progeria syndrome involves progerin clearance by the activation of the AMPK-mTOR-autophagy pathway Geroscience (IF 5.3) Pub Date : 2025-01-16 Feliciano Monterrubio-Ledezma, Ashley Salcido-Gómez, Tania Zavaleta-Vásquez, Fernando Navarro-García, Bulmaro Cisneros, Lourdes Massieu
D-β-hydroxybutyrate, BHB, has been previously proposed as an anti-senescent agent in vitro and in vivo in several tissues including vascular smooth muscle. Moreover, BHB derivatives as ketone esters alleviate heart failure. Here, we provide evidence of the potential therapeutic effect of BHB on Hutchinson-Gilford progeria syndrome (HGPS), a rare condition characterized by premature aging and heart
-
Accelerated epigenetic ageing after burn injury Geroscience (IF 5.3) Pub Date : 2025-01-16 Jack Sullivan, Thomas Nicholson, Jon Hazeldine, Naiem Moiemen, Janet M. Lord
Individuals who suffer a major burn injury are at higher risk of developing a range of age-associated diseases prematurely leading to an increase in mortality in adult and juvenile burn injury survivors. One possible explanation is that injury is accelerating the biological ageing process. To test this hypothesis, we analysed DNA methylation in peripheral blood mononuclear cells from adult burn-injured
-
Age-specific effects of a sustained cognitive activity on perceived cognitive fatigue as well as single- and dual-task treadmill walking performance Geroscience (IF 5.3) Pub Date : 2025-01-15 Martin Schlegel, Matthias Weippert, Frank Feldhege, Franziska Knaack, Thomas Mittlmeier, Sven Bruhn, Martin Behrens
During their daily lives humans are often confronted with sustained cognitive activities (SCA) leading to state fatigue, a psychobiological state characterized by a decrease in cognitive and/or motor performance and/or an increase in perception of fatigue. It was recently shown that performing SCA can impair overground dual-task gait performance in older adults, but it is currently unknown whether
-
Analysis of sex-specific disease patterns associated with human lifespan Geroscience (IF 5.3) Pub Date : 2025-01-15 Sara Cruces-Salguero, Joaquim Sol, Igor Larrañaga, Reinald Pamplona, Javier Mar, Mariona Jove, Ander Matheu
Disability and multimorbidity increase with aging and constitute a challenge for the health system. However, different individuals display different aging trajectories, and understanding the underlying relationships between lifespan and disease is fundamental for identifying the different patterns in human lifespan. A previous study explored associations between lifespan and age of onset of diseases
-
The impact of co-housing on murine aging studies Geroscience (IF 5.3) Pub Date : 2025-01-14 Alison Luciano, Gary A. Churchill
Analysis of preclinical lifespan studies often assume that outcome data from co-housed animals are independent. In practice, treatments, such as controlled feeding or putative life-extending compounds, are applied to whole housing units, and as a result, the outcomes are potentially correlated within housing units. We consider intra-class (here, intra-cage) correlation in three published and two unpublished
-
Enhancing emergency care for older persons: the role and impact of the electronic Frailty Index Geroscience (IF 5.3) Pub Date : 2025-01-13 Dana Shiffer, Antonio Desai, Matteo Cesari, Elena Generali, Massimiliano Greco, Gabriele Savioli, Mauro Giordano, Antonio Voza
As the elderly population expands, enhancing emergency department (ED) care by assessing frailty becomes increasingly vital. To address this, we developed a novel electronic Frailty Index (eFI) from ED health records, specifically designed to assess frailty and predict hospitalization, in-hospital mortality, ICU admissions, and 30-day ED readmissions. This retrospective, single-center study included
-
High prevalence of atrial conduction abnormalities in Lewy body disease – a marker of cardiac complications? Geroscience (IF 5.3) Pub Date : 2025-01-10 Keivan Javanshiri, Alexander Siotis, Isak Heyman, Mattias Haglund
Increasing evidence suggests that Lewy body disease (LBD) is associated with clinically important cardiac complications, including sick sinus syndrome, atrial fibrillation and sudden cardiac death. The high prevalence of sick sinus syndrome and atrial fibrillation in LBD suggests the presence of disease-related atrial conduction disorders. To explore whether LBD is associated with atrial conduction